Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to investigate the potential role of vitamin D in DSS-induced colitis, thereby providing novel insights into the clinical management of intestinal diseases.

Source: 1. Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

After 1 week of adaptive feeding, the mice were randomly allocated into four groups with equal sample sizes (n = 5).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Modified DSS-Induced Colitis in Mice via STING Signaling Pathway

Study design awaiting verification · Biology · 2025

Original publication title

Vitamin D Modified DSS-Induced Colitis in Mice via STING Signaling Pathway

Zhihao Wu; Baohua Ma; Min Xiao; Qian Ren; Yanhua Shen; Zhengyu Zhou

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Simple Summary

Previous research has established a correlation between low levels of vitamin D and the severity of inflammatory bowel disease. Our study provides evidence that vitamin D supplementation significantly mitigated colitis induced by dextran sulfate sodium through the suppression of dysregulated immune responses, reduction in inflammation, and restoration of gut microbiota equilibrium. Mechanistically, vitamin D exerts its effects by inhibiting the activation of the GATA1/STING signaling pathway, which leads to a downregulation of type I interferon production and the release of inflammatory cytokines.

These actions are instrumental in maintaining the integrity of the intestinal barrier and alleviating gut dysbiosis, a characteristic feature of IBD. Vitamin D not only reduces pro-inflammatory cytokines but also promotes the proliferation of beneficial microbial communities, underscoring its dual role in immune regulation and microbiota homeostasis. In general, the modulation of the STING pathway by vitamin D indicates a potential novel therapeutic approach for the management of IBD.

Abstract

Although the underlying mechanisms are not yet fully understood, vitamin D has been proven to be associated with the pathogenesis of inflammatory bowel disease, participating in immune response and regulating gut microbiota composition. In this study, we established a dextran sodium sulfate-induced colitis model and intervened with vitamin D. Subsequently, colonic histopathology, serum biochemistry, transcription of inflammatory cytokines, gut microbiota, and key signaling pathways were examined. Our research demonstrated that intervention with vitamin D reduced the disease activity index of DSS-induced colitis and improved histopathological changes, protecting tight junction protein ZO-1 and intestinal glands from damage induced by DSS.

Analysis of gut microbiota revealed alterations in both α diversity and β diversity in DSS-induced colitis, whereas interventions with active vitamin D corrected the changes in certain bacterial abundance and improved the composition of gut microbiota. The transcription levels of inflammatory cytokines, including IL-23, IL-1β, IFN-γ, IL-6, IL-17, and STING, were elevated in the DSS-induced colitis model. However, intervention with active vitamin D effectively suppressed the transcription of these factors. Finally, immunohistochemistry and Western blotting revealed that the intervention with vitamin D suppressed the expression of proteins associated with the STING pathway, including GATA1, STING, IRF3, and IKBα, leading to inhibition of downstream IFN-β production.

Vitamin D administration can ameliorate the severity of DSS-induced colitis by preserving intestinal barrier integrity, modulating gut microbiota composition through suppression of the STING pathway.

Authors’ abstract

Simple Summary

Previous research has established a correlation between low levels of vitamin D and the severity of inflammatory bowel disease. Our study provides evidence that vitamin D supplementation significantly mitigated colitis induced by dextran sulfate sodium through the suppression of dysregulated immune responses, reduction in inflammation, and restoration of gut microbiota equilibrium. Mechanistically, vitamin D exerts its effects by inhibiting the activation of the GATA1/STING signaling pathway, which leads to a downregulation of type I interferon production and the release of inflammatory cytokines.

These actions are instrumental in maintaining the integrity of the intestinal barrier and alleviating gut dysbiosis, a characteristic feature of IBD. Vitamin D not only reduces pro-inflammatory cytokines but also promotes the proliferation of beneficial microbial communities, underscoring its dual role in immune regulation and microbiota homeostasis. In general, the modulation of the STING pathway by vitamin D indicates a potential novel therapeutic approach for the management of IBD.

Abstract

Although the underlying mechanisms are not yet fully understood, vitamin D has been proven to be associated with the pathogenesis of inflammatory bowel disease, participating in immune response and regulating gut microbiota composition. In this study, we established a dextran sodium sulfate-induced colitis model and intervened with vitamin D. Subsequently, colonic histopathology, serum biochemistry, transcription of inflammatory cytokines, gut microbiota, and key signaling pathways were examined. Our research demonstrated that intervention with vitamin D reduced the disease activity index of DSS-induced colitis and improved histopathological changes, protecting tight junction protein ZO-1 and intestinal glands from damage induced by DSS.

Analysis of gut microbiota revealed alterations in both α diversity and β diversity in DSS-induced colitis, whereas interventions with active vitamin D corrected the changes in certain bacterial abundance and improved the composition of gut microbiota. The transcription levels of inflammatory cytokines, including IL-23, IL-1β, IFN-γ, IL-6, IL-17, and STING, were elevated in the DSS-induced colitis model. However, intervention with active vitamin D effectively suppressed the transcription of these factors. Finally, immunohistochemistry and Western blotting revealed that the intervention with vitamin D suppressed the expression of proteins associated with the STING pathway, including GATA1, STING, IRF3, and IKBα, leading to inhibition of downstream IFN-β production.

Vitamin D administration can ameliorate the severity of DSS-induced colitis by preserving intestinal barrier integrity, modulating gut microbiota composition through suppression of the STING pathway.

Publication and source details

Original title: Vitamin D Modified DSS-Induced Colitis in Mice via STING Signaling Pathway

Zhihao Wu; Baohua Ma; Min Xiao; Qian Ren; Yanhua Shen; Zhengyu Zhou

Biology · 2025

* Correspondence: zacharyzhou@suda.edu.cn; Tel.: +86-0512-65880708
†

These authors contributed equally to this work.

© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:45:32.851722+00:00

DOI: 10.3390/biology14060715 · PMC12190092